Background: Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPH)
are pulmonary vascular disorders which occur in patients with severe liver disease and/or …

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are distinct
clinical entities that may complicate liver disease. Although HPS and PPHTN are different …

Background: Portopulmonary hypertension and hepatopulmonary syndrome have been
considered mutually exclusive pulmonary vascular disorders in liver disease states …

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PortoPH) are
pulmonary vascular consequences of advanced liver disease associated with significant …

Hepatopulmonary syndrome (HPS)(hypoxaemia due to intrapulmonary vasodilation and a
right‐to‐left shunt associated with liver disease) resolves after liver transplantation. The …

Objectives: The hepatopulmonary syndrome (HPS) is characterized as a triad: liver disease,
intrapulmonary vascular dilatatiton, and arterial hypoxemia. The aim of this study is to …

Abstract Purpose of Review Hepatopulmonary syndrome (HPS) and portopulmonary
hypertension (PoPH) are both pulmonary vascular complications of advanced liver disease; …

Hepatopulmonary syndrome and portopulmonary hypertension are the most common
pulmonary vascular complications in patients with cirrhosis. Usually but not universally …

PURPOSE: Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPH) are
poorly understood pulmonary complications of end-stage liver disease (ESLD). We present …

BACKGROUND: Hepatopulmomary syndrome is defined by the triad of chronic liver
disease, increased alveolar-arterial gradient, and evidence of intrapulmonary vasodilation. It …